Will he manage to stay true to himself without getting caught up in the role? An in-depth look by Massimo Callegari.

If you only move in a straight line, you might be missing a critical way to keep your hips strong. Experts say adding this ...

Scientific evidence, regulatory framework, and training: first aid enters institutions with a forum that brings together ...

Global life sciences giant Danaher coughed up a pretty penny to buy Masimo this week, spending roughly $10 billion to beef up its diagnostics portfolio. The deal values medical device developer Masimo ...

The firm initiated a new position by purchasing about 1.6 million shares. It position equals 15.3% of the fund’s 13F assets under management. Initiated a new position valued at about $203 million ...

Danaher, the NYSE-listed biotechnology and diagnostics company, is to acquire Masimo Corporation, the California-based firm best known for its development of optical pulse oximetry devices widely used ...

In this week’s edition of InnovationRx, we look at Danaher’s $10 billion acquisition of Masimo, Jennifer Doudna’s $1 billion plan to bring Crispr gene editing to the real world, using “boring” AI in ...

Masimo stock (MASI) has faced a challenging year, trailing the broader market with a -3% annual return. While shares surged 34% yesterday following news of an acquisition by Danaher, this spike only ...

Danaher (DHR) is acquiring Masimo for $9.9B at $180 per share. This represents a 40% premium. Masimo shares jumped 30.27% toward the deal price. Danaher stock fell 6.09% on integration concerns.

We recently published 10 Stocks Outperforming With Monstrous Gains. Masimo Corporation (NASDAQ:MASI) was one of the best performers on Tuesday. Masimo Corp. snapped a two-day losing streak on Tuesday, ...

Masimo shares rocketed after biotech conglomerate Danaher struck a deal to acquire the medical-device maker for almost $10 billion. Masimo shares (MASI) surged by roughly one-third Tuesday morning to ...

Wed, February 18, 2026 at 1:50 PM UTC Danaher (NYSE: DHR) is acquiring Masimo (NASDAQ: MASI) for $9.9 billion in an all-cash deal that values the medical technology company at $180 per share. The ...